newsfilter
← Latest News
Business Wire·

Glaukos Completes Acquisition of Avedro, Inc.

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has completed its previously announced acquisition of Avedro, Inc. (Nasdaq: AVDR).